mefloquine has been researched along with arterolane in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Charman, SA; Chiu, FC; Chollet, J; Dong, Y; Katneni, K; Mannila, J; Morizzi, J; Ryan, E; Santo Tomas, J; Scheurer, C; Snyder, C; Steuten, J; Vennerstrom, JL; Wang, X; Wittlin, S | 1 |
| Biamonte, MA; Le Roch, KG; Wanner, J | 1 |
| Fidock, DA; Flannery, EL; Winzeler, EA | 1 |
| Bogyo, M; Charman, SA; Fontaine, SD; Gut, J; Katneni, K; Lauterwasser, EM; Li, H; Renslo, AR; Rosenthal, PJ | 1 |
| Barker, H; Bulbule, VJ; Charman, SA; Charman, WN; Chiu, FC; Chollet, J; Dhanasekaran, M; Dong, Y; Hein, CD; Kamaraj, S; Matile, H; Morizzi, J; Papastogiannidis, P; Ryan, E; Scheurer, C; Shackleford, DM; Tang, Y; Urwyler, H; Vennerstrom, JL; Wang, X; White, KL; Wittlin, S; Zhao, Q; Zhou, L | 1 |
| Bassat, Q; Varo, R | 1 |
| Bejon, P; Boga, M; Day, NPJ; Dhorda, M; Dondorp, AM; Gonçalves, S; Hamaluba, M; Hoglund, RM; Imwong, M; Kalume, P; Khuroo, A; Lal, AA; Miotto, O; Mturi, N; Mukaka, M; Mutinda, B; Mwambingu, G; Ngama, M; Ngetsa, C; Njuguna, P; Tarning, J; Taylor, WRJ; van der Pluijm, RW; Waithira, N; Wambua, J; Weya, J; White, NJ | 1 |
2 review(s) available for mefloquine and arterolane
| Article | Year |
|---|---|
Recent advances in malaria drug discovery.
Topics: Animals; Antimalarials; Drug Discovery; Humans; Liver; Liver Transplantation; Malaria; Molecular Structure | 2013 |
Using genetic methods to define the targets of compounds with antimalarial activity.
Topics: Animals; Anopheles; Antimalarials; Drug Resistance; Genetic Association Studies; Genome, Protozoan; Humans; Malaria, Falciparum; Molecular Targeted Therapy; Plasmodium falciparum | 2013 |
1 trial(s) available for mefloquine and arterolane
| Article | Year |
|---|---|
Arterolane-piperaquine-mefloquine versus arterolane-piperaquine and artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial.
Topics: Administration, Oral; Antimalarials; Artemether, Lumefantrine Drug Combination; Child; Child, Preschool; Female; Heterocyclic Compounds, 1-Ring; Humans; Kenya; Malaria, Falciparum; Male; Mefloquine; Peroxides; Plasmodium falciparum; Quinolines; Spiro Compounds; Treatment Outcome | 2021 |
4 other study(ies) available for mefloquine and arterolane
| Article | Year |
|---|---|
Comparative antimalarial activities and ADME profiles of ozonides (1,2,4-trioxolanes) OZ277, OZ439, and their 1,2-dioxolane, 1,2,4-trioxane, and 1,2,4,5-tetraoxane isosteres.
Topics: Absorption; Adamantane; Animals; Antimalarials; Dioxolanes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Male; Mice; Peroxides; Plasmodium berghei; Plasmodium falciparum; Spiro Compounds; Structure-Activity Relationship; Tetraoxanes | 2013 |
Trioxolane-Mediated Delivery of Mefloquine Limits Brain Exposure in a Mouse Model of Malaria.
Topics: | 2015 |
Structure-Activity Relationship of the Antimalarial Ozonide Artefenomel (OZ439).
Topics: Adamantane; Animals; Antimalarials; Female; Malaria; Male; Mice; Peroxides; Plasmodium berghei; Plasmodium falciparum; Rats; Structure-Activity Relationship | 2017 |
Arterolane-based combinations for the treatment of uncomplicated falciparum malaria in Kenyan children.
Topics: Antimalarials; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Female; Heterocyclic Compounds, 1-Ring; Humans; Kenya; Malaria, Falciparum; Male; Mefloquine; Peroxides; Plasmodium falciparum; Quinolines; Spiro Compounds | 2021 |